- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
S&P 500 (NYSE:SPY) component Bristol-Myers Squibb (NYSE:BMY) will unveil its latest earnings tomorrow, Thursday, January 24, 2013. Bristol-Myers Squibb is a global company that develops, manufactures, and sells pharmaceutical products.
Bristol-Myers Squibb Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 43 cents per share, a decline of 18.9% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 40 cents. Between one and three months ago, the average estimate moved up. It has dropped from 44 cents during the last month. Analysts are projecting profit to rise by 14.5% compared to last year’s $1.95.
Past Earnings Performance: The company is hoping to beat estimates after missing the mark for two straight quarters. Last quarter, it reported net income of 37 cents per share against an estimate of profit of 41 cents per share. The quarter before that, it missed forecasts by one cent.
Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!
A Look Back: In the third quarter, the company swung to a loss of $711 million (43 cents a share) from a profit of $969 million (56 cents) a year earlier, missing analyst expectations. Revenue fell 30.1% to $3.74 billion from $5.34 billion.
Here’s how Bristol-Myers Squibb traded following its last earnings report 3 months ago and leading up to its upcoming earnings report this week:
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.